Dr. Ma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5901 E Seventh St
Long Beach, CA 90822
Summary
- Dr. Helen Ma is a hematologist and oncologist in Long Beach, CA and is affiliated with VA Long Beach and University of California Irvine. She specializes in hematologic oncology and is experienced hematology and oncology.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
NYU Grossman School of MedicineResidency, Internal Medicine, 2014 - 2017
Geisel School of Medicine at DartmouthClass of 2014
Certifications & Licensure
CA State Medical License 2020 - 2026
NY State Medical License 2015 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A case report of solitary presentations of large B-cell lymphoma of immune-privileged sites (IP-LBCL) in the testis, vitreous body, and skin.Jeffrey Ahn, Yi Ouyang, Graham Velasco, Ann Eapen, Helen Ma
Leukemia & Lymphoma. 2024-12-01 - 1 citationsPeripheral T-cell lymphoma: From biology to practice to the future.Owen A O'Connor, Helen Ma, Jason Yong Sheng Chan, Seok Jin Kim, Sang Eun Yoon
Cancer Treatment Reviews. 2024-09-01 - A retrospective analysis of factors impacting survival in United States military veterans with multiple myeloma.Sharmeen Mahmood, Pankaj Gupta, Helen Ma
Leukemia & Lymphoma. 2024-04-01
Abstracts/Posters
- Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)Helen Ma, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Survival outcomes of patients with peripheral T-cell lymphomas (PTCL) treated with chemotherapy and/or novel agents: The Columbia University experience.2019 ASCO Annual Meeting - 6/1/2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
